SAFC Expands Gene Therapy MfgBy
SAFC Commercial, Sigma-Aldrich Corporation's custom manufacturing business unit, will expand its existing facility in Carlsbad, California to enable SAFC to offer clinical and commercial bulk drug production, as well as fill/finish of viral products for gene therapy, viral vaccine, and immunotherapy products.
The expanded Carlsbad facility complements a global footprint of GMP services for SAFC in the virus and gene therapy segment, including cell banking in Rockville, Maryland, and manufacturing at its site in Glasgow, Scotland. The investment was driven by continued interest in targeted gene therapies for indications such as hemophilia and cancer immunotherapies (CAR-T cells). The Carlsbad facility provides a full range of GMP manufacturing and testing services.